Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

4.020
-0.015-0.37%
Volume:8.99M
Turnover:36.41M
Market Cap:1.84B
PE:-5.09
High:4.190
Open:4.080
Low:3.950
Close:4.035
52wk High:51.700
52wk Low:3.880
Shares:457.00M
HK Float Shares:420.29M
Volume Ratio:1.05
T/O Rate:2.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.790
ROE:-36.91%
ROA:-17.30%
PB:1.50
PE(LYR):-5.09
PS:11.98

Loading ...

INNOGEN-B: 韩投伙伴(上海)创业投资管理有限责任公司 Disposes of Shares, Long Position Falls to 8.73%

HK Disclosure
·
Aug 19

INNOGEN-B: Li Huang Disposes of Shares, Long Position Falls to 9.19%

HK Disclosure
·
Aug 19

INNOGEN-B: KIP KIS SEA-CHINA Fund Disposes of Shares, Long Position Falls to 5.61%

HK Disclosure
·
Aug 19

INNOGEN-B: KOREA INVESTMENT HOLDINGS Co., Ltd. Disposes of Shares, Long Position Falls to 8.73%

HK Disclosure
·
Aug 19

INNOGEN-B: Cowin Capital Investment III Limited Disposes of Shares, Long Position Falls to 5.95%

HK Disclosure
·
Aug 19

INNOGEN-B: 景得(广州)股权投资合伙企业(有限合伙) Disposes of Shares, Long Position Falls to 5.61%

HK Disclosure
·
Aug 19

INNOGEN-B: Cowin Capital Investment Limited Disposes of Shares, Long Position Falls to 5.95%

HK Disclosure
·
Aug 19

Hong Kong Stock Market Update | INNOGEN-B (02591) Drops Over 5% to Hit New Low as Shareholder Trims Stake Post Lock-up Expiry

Stock News
·
Aug 19

Huang Li Reduces Stake in INNOGEN-B (02591) by 3.35 Million Shares at Approximately HK$5.03 Each

Stock News
·
Aug 18

INNOGEN-B: Weihe Zheng Disposes of Shares, Long Position Falls to 9.67%

HK Disclosure
·
Aug 18

1.89 Billion Hong Kong Dollar Deposit Value for INNOGEN-B as Shareholders Transfer 26.56 Million Shares to Haitong International Securities

Stock News
·
Aug 14

Guangzhou Innogen Pharmaceutical Schedules 25 Aug Board Meeting to Approve 1H 2026 Results and Consider Interim Dividend

Bulletin Express
·
Aug 13

Guangzhou Innogen Pharma Schedules Board Meeting on Interim Results, Dividend Review

Reuters
·
Aug 13

INNOGEN-B Maintains Stable Share Capital Structure in July 2026; Confirms Public Float Compliance

Bulletin Express
·
Aug 05

Innogen Pharma's Efsubaglutide Manufacturing Sites Receive Brazil GMP Certification

MT Newswires Live
·
Aug 04

Hong Kong Stock Movers: INNOGEN-B Surges Over 18% in Early Trading After Two Suzhou Pegloticase Alpha Injection Contract Sites Achieve PIC/S GMP Certification

Stock News
·
Aug 04

INNOGEN-B (02591) Secures PIC/S GMP Certificates for Two Supplier Sites of Its Key Drug Candidate

Stock News
·
Aug 03

Guangzhou Innogen Pharmaceutical - Obtainment of Pic/S Gmp Certificates for Two Contract Manufacturing Sites for Efsubaglutide Alfa Injection

THOMSON REUTERS
·
Aug 03

Guangzhou Innogen Says Anvisa Grants PIC/S GMP Certificates for Two Contract Sites for Ecnoglutide Alpha Injection

Reuters
·
Aug 03

INNOGEN-B (02591) Depositary Shares Valued at HK$188 Million; Shareholder Deposits 25.29 Million Shares with Citibank

Stock News
·
Jul 31